Obesity, a multi-system disease that affects almost 1 billion people worldwide, is arguably the biggest health challenge.
The main bariatric procedures in 2026 remain sleeve gastrectomy and Roux-en-Y gastric bypass.
Other procedures exist, but these two are the most widely discussed with patients.
The 2026 review in Oxford Open Endocrinology notes that sleeve gastrectomy is currently the most commonly performed bariatric surgery worldwide, followed by Roux-en-Y gastric bypass.
Procedure choice depends on more than weight.
A surgeon may consider:
- Reflux symptoms
- Diabetes severity
- BMI
- Eating pattern
- Medication use
- Previous surgery
- Hernia history
- Risk profile
- Patient preference
- Long-term supplement compliance
Patients should not choose a procedure based on social media results.
The best choice is the one that fits the patient’s health profile and long-term ability to manage follow-up.
Sleeve Gastrectomy
Sleeve gastrectomy removes a large portion of the stomach and creates a narrower stomach tube.
It limits food volume and affects appetite hormones.
It is popular because it is technically simpler than gastric bypass and does not reroute the small intestine.
But it is not “minor surgery”.
It is permanent.
It can worsen reflux in some patients.
It still requires long-term nutrition follow-up.
The 2026 review notes that sleeve gastrectomy is the most commonly performed bariatric procedure worldwide.
Sleeve may suit selected patients who do not have severe reflux and who need a strong metabolic and weight-loss tool.
Patients should ask:
Will sleeve worsen my reflux?
How much weight loss is realistic?
What are the leak risks?
What vitamins will I need?
What is the plan if weight regain occurs?
Roux-en-Y Gastric Bypass
Roux-en-Y gastric bypass creates a small stomach pouch and reroutes part of the small intestine.
It can produce strong weight loss and may be especially useful for selected patients with type 2 diabetes or reflux disease.
It is more complex than sleeve gastrectomy.
It may carry higher risk of internal hernia, dumping symptoms, marginal ulcers, and micronutrient deficiencies.
It requires disciplined long-term supplementation.
The 2026 review states that in the STAMPEDE trial, Roux-en-Y gastric bypass and sleeve gastrectomy both produced significantly greater weight loss than medical therapy alone in adults with obesity and type 2 diabetes, with effects sustained at five years.
Bypass may be preferred when reflux is a major issue.
It may also be considered when stronger metabolic effect is needed.
The decision must be individual.
Source Credit: https://academic.oup.com/obendo/article/2/1/wjag004/8497417?login=false